Without warning stroke can paralyze, blind, or kill. Some victims recover, but many do not and may even suffer another disabling or fatal attack. The drug known as tPA can drastically reduce the long-term disability associated with stroke, but despite its near-miraculous capabilities and the growing support of most neurologists, it has been slow to win acceptance as the standard of care in emergency departments nationwide. tPA for Stroke chronicles how this remarkable drug came to be tested in stroke victims, its early years in development by the pharmaceutical giant Genentech, and its eventual marginalization due to a convergence of unfavorable political, fiscal, and medical circumstances. For instance, initially many stroke specialists were unconvinced that the drug's benefits outweigh its risks (tPA was originally developed and is still used for cardiac patients). Moreover, neurologists called upon to assess stroke patients have not typically been trained to make decisions in emergency settings--and tPA must be given within a scant few hours after stroke. These and other factors have continued to delay the drug's universal acceptance as the most effective treatment available, and to hamper the general public's awareness that such a treatment exists--a troubling state of affairs that Zivin and Simmons argue must be rectified. Instilling the knowledge that anyone, at any time, is susceptible to stroke, from the old and infirm to the young and healthy, tPA for Stroke is a clarion call to awareness in a rapidly changing healthcare environment in which stroke, long a disease in thrall to resignation and pessimism, must be neglected no longer.

This report presents background and analysis on the development of Trade Promotion Authority (TPA), which expired on July 1, 2007. The report also includes a summary of the major provisions under the recently expired authority and a discussion of the issues that have arisen in the debate over TPA renewal. It also explores the policy options available to Congress and will be updated as the congressional debate unfolds.

The fourth edition enhanced eBook update of Product and Process Design Principles contains many new resources and supplements including new videos, quiz questions with answer-specific feedback, and real-world case studies to support student comprehension. Product and Process Design Principles covers material for process design courses in the chemical engineering curriculum—demonstrating how process design and product design are interlinked and their importance for modern applications. Presenting a systematic approach, this fully-updated new edition describes modern strategies for the design of chemical products and processes. The text presents two parallel tracks—product design and process design—which enables instructors to easily show how product designs lead to new chemical processes and, alternatively, teach product design as separate course. Divided into five parts, the fourth edition begins with a broad introduction to product design followed by a comprehensive introduction to process synthesis and analysis. Succeeding chapters cover the products and processes of design synthesis, design analysis, and design reports. The final part of the book presents ten case studies which look at product and process designs such as for Vitamin C tablets, conductive ink for printed electronics, and home hemodialysis devices. Effective pedagogical tools are thoroughly and consistently implemented throughout the text.